Research ArticleDrug Discovery and Translational Medicine
The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models
Antonio Caprioli, Roberto Coccurello, Cinzia Rapino, Stefano Di Serio, Monia Di Tommaso, Mario Vertechy, Valentina Vacca, Natalia Battista, Flaminia Pavone, Mauro Maccarrone and Franco Borsini
Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 188-195; DOI: https://doi.org/10.1124/jpet.111.191403
Antonio Caprioli
Roberto Coccurello
Cinzia Rapino
Stefano Di Serio
Monia Di Tommaso
Mario Vertechy
Valentina Vacca
Natalia Battista
Flaminia Pavone
Mauro Maccarrone
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleDrug Discovery and Translational Medicine
Fatty Acid Amide Hydrolase Inhibition and Neuropathic Pain
Antonio Caprioli, Roberto Coccurello, Cinzia Rapino, Stefano Di Serio, Monia Di Tommaso, Mario Vertechy, Valentina Vacca, Natalia Battista, Flaminia Pavone, Mauro Maccarrone and Franco Borsini
Journal of Pharmacology and Experimental Therapeutics July 1, 2012, 342 (1) 188-195; DOI: https://doi.org/10.1124/jpet.111.191403
Research ArticleDrug Discovery and Translational Medicine
Fatty Acid Amide Hydrolase Inhibition and Neuropathic Pain
Antonio Caprioli, Roberto Coccurello, Cinzia Rapino, Stefano Di Serio, Monia Di Tommaso, Mario Vertechy, Valentina Vacca, Natalia Battista, Flaminia Pavone, Mauro Maccarrone and Franco Borsini
Journal of Pharmacology and Experimental Therapeutics July 1, 2012, 342 (1) 188-195; DOI: https://doi.org/10.1124/jpet.111.191403
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement